Market Analysis and Insights: Global Insomnia Therapy Market
The research report studies the Insomnia Therapy market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Insomnia Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Insomnia Therapy Scope and Segment
The global Insomnia Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insomnia Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Non-pharmacological Therapy
Pharmacological Therapy
by Application, this report covers the following segments
Hospital
Ambulatory Surgical Center
Home Care
Global Insomnia Therapy market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Insomnia Therapy key players in this market include:
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
The research report studies the Insomnia Therapy market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Insomnia Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Insomnia Therapy Scope and Segment
The global Insomnia Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insomnia Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Non-pharmacological Therapy
Pharmacological Therapy
by Application, this report covers the following segments
Hospital
Ambulatory Surgical Center
Home Care
Global Insomnia Therapy market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Insomnia Therapy key players in this market include:
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
1 Market Overview of Insomnia Therapy
1.1 Insomnia Therapy Market Overview
1.1.1 Insomnia Therapy Product Scope
1.1.2 Insomnia Therapy Market Status and Outlook
1.2 Global Insomnia Therapy Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Insomnia Therapy Market Size by Region (2016-2027)
1.4 Global Insomnia Therapy Historic Market Size by Region (2016-2021)
1.5 Global Insomnia Therapy Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Insomnia Therapy Market Size (2016-2027)
1.6.1 North America Insomnia Therapy Market Size (2016-2027)
1.6.2 Europe Insomnia Therapy Market Size (2016-2027)
1.6.3 Asia-Pacific Insomnia Therapy Market Size (2016-2027)
1.6.4 Latin America Insomnia Therapy Market Size (2016-2027)
1.6.5 Middle East & Africa Insomnia Therapy Market Size (2016-2027)
2 Insomnia Therapy Market Overview by Type
2.1 Global Insomnia Therapy Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Insomnia Therapy Historic Market Size by Type (2016-2021)
2.3 Global Insomnia Therapy Forecasted Market Size by Type (2022-2027)
2.4 Non-pharmacological Therapy
2.5 Pharmacological Therapy
3 Insomnia Therapy Market Overview by Application
3.1 Global Insomnia Therapy Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Insomnia Therapy Historic Market Size by Application (2016-2021)
3.3 Global Insomnia Therapy Forecasted Market Size by Application (2022-2027)
3.4 Hospital
3.5 Ambulatory Surgical Center
3.6 Home Care
4 Insomnia Therapy Competition Analysis by Players
4.1 Global Insomnia Therapy Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2020)
4.3 Date of Key Players Enter into Insomnia Therapy Market
4.4 Global Top Players Insomnia Therapy Headquarters and Area Served
4.5 Key Players Insomnia Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Insomnia Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Merck & Co.
5.1.1 Merck & Co. Profile
5.1.2 Merck & Co. Main Business
5.1.3 Merck & Co. Insomnia Therapy Products, Services and Solutions
5.1.4 Merck & Co. Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.1.5 Merck & Co. Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Insomnia Therapy Products, Services and Solutions
5.2.4 Sanofi Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.2.5 Sanofi Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Insomnia Therapy Products, Services and Solutions
5.3.4 Pfizer Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.3.5 Takeda Pharmaceutical Company Ltd. Recent Developments
5.4 Takeda Pharmaceutical Company Ltd.
5.4.1 Takeda Pharmaceutical Company Ltd. Profile
5.4.2 Takeda Pharmaceutical Company Ltd. Main Business
5.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Products, Services and Solutions
5.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
5.5 Purdue Pharmaceuticals L.P.
5.5.1 Purdue Pharmaceuticals L.P. Profile
5.5.2 Purdue Pharmaceuticals L.P. Main Business
5.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Products, Services and Solutions
5.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.5.5 Purdue Pharmaceuticals L.P. Recent Developments
5.6 Eisai, Co. Ltd.
5.6.1 Eisai, Co. Ltd. Profile
5.6.2 Eisai, Co. Ltd. Main Business
5.6.3 Eisai, Co. Ltd. Insomnia Therapy Products, Services and Solutions
5.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.6.5 Eisai, Co. Ltd. Recent Developments
5.7 Meda Consumer Healthcare
5.7.1 Meda Consumer Healthcare Profile
5.7.2 Meda Consumer Healthcare Main Business
5.7.3 Meda Consumer Healthcare Insomnia Therapy Products, Services and Solutions
5.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.7.5 Meda Consumer Healthcare Recent Developments
5.8 Pernix Therapeutics
5.8.1 Pernix Therapeutics Profile
5.8.2 Pernix Therapeutics Main Business
5.8.3 Pernix Therapeutics Insomnia Therapy Products, Services and Solutions
5.8.4 Pernix Therapeutics Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.8.5 Pernix Therapeutics Recent Developments
5.9 Vanda Pharmaceuticals
5.9.1 Vanda Pharmaceuticals Profile
5.9.2 Vanda Pharmaceuticals Main Business
5.9.3 Vanda Pharmaceuticals Insomnia Therapy Products, Services and Solutions
5.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.9.5 Vanda Pharmaceuticals Recent Developments
5.10 ECR Pharmaceuticals
5.10.1 ECR Pharmaceuticals Profile
5.10.2 ECR Pharmaceuticals Main Business
5.10.3 ECR Pharmaceuticals Insomnia Therapy Products, Services and Solutions
5.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.10.5 ECR Pharmaceuticals Recent Developments
5.11 Fidia Farmaceutici
5.11.1 Fidia Farmaceutici Profile
5.11.2 Fidia Farmaceutici Main Business
5.11.3 Fidia Farmaceutici Insomnia Therapy Products, Services and Solutions
5.11.4 Fidia Farmaceutici Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.11.5 Fidia Farmaceutici Recent Developments
5.12 Dainippon Sumitomo
5.12.1 Dainippon Sumitomo Profile
5.12.2 Dainippon Sumitomo Main Business
5.12.3 Dainippon Sumitomo Insomnia Therapy Products, Services and Solutions
5.12.4 Dainippon Sumitomo Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.12.5 Dainippon Sumitomo Recent Developments
5.13 Biocodex
5.13.1 Biocodex Profile
5.13.2 Biocodex Main Business
5.13.3 Biocodex Insomnia Therapy Products, Services and Solutions
5.13.4 Biocodex Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.13.5 Biocodex Recent Developments
5.14 Eli Lilly and Company
5.14.1 Eli Lilly and Company Profile
5.14.2 Eli Lilly and Company Main Business
5.14.3 Eli Lilly and Company Insomnia Therapy Products, Services and Solutions
5.14.4 Eli Lilly and Company Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.14.5 Eli Lilly and Company Recent Developments
5.15 Ebb Therapeutics
5.15.1 Ebb Therapeutics Profile
5.15.2 Ebb Therapeutics Main Business
5.15.3 Ebb Therapeutics Insomnia Therapy Products, Services and Solutions
5.15.4 Ebb Therapeutics Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.15.5 Ebb Therapeutics Recent Developments
6 North America
6.1 North America Insomnia Therapy Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapy Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Insomnia Therapy Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapy Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Insomnia Therapy Market Dynamics
11.1 Insomnia Therapy Industry Trends
11.2 Insomnia Therapy Market Drivers
11.3 Insomnia Therapy Market Challenges
11.4 Insomnia Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Au
1.1 Insomnia Therapy Market Overview
1.1.1 Insomnia Therapy Product Scope
1.1.2 Insomnia Therapy Market Status and Outlook
1.2 Global Insomnia Therapy Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Insomnia Therapy Market Size by Region (2016-2027)
1.4 Global Insomnia Therapy Historic Market Size by Region (2016-2021)
1.5 Global Insomnia Therapy Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Insomnia Therapy Market Size (2016-2027)
1.6.1 North America Insomnia Therapy Market Size (2016-2027)
1.6.2 Europe Insomnia Therapy Market Size (2016-2027)
1.6.3 Asia-Pacific Insomnia Therapy Market Size (2016-2027)
1.6.4 Latin America Insomnia Therapy Market Size (2016-2027)
1.6.5 Middle East & Africa Insomnia Therapy Market Size (2016-2027)
2 Insomnia Therapy Market Overview by Type
2.1 Global Insomnia Therapy Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Insomnia Therapy Historic Market Size by Type (2016-2021)
2.3 Global Insomnia Therapy Forecasted Market Size by Type (2022-2027)
2.4 Non-pharmacological Therapy
2.5 Pharmacological Therapy
3 Insomnia Therapy Market Overview by Application
3.1 Global Insomnia Therapy Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Insomnia Therapy Historic Market Size by Application (2016-2021)
3.3 Global Insomnia Therapy Forecasted Market Size by Application (2022-2027)
3.4 Hospital
3.5 Ambulatory Surgical Center
3.6 Home Care
4 Insomnia Therapy Competition Analysis by Players
4.1 Global Insomnia Therapy Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2020)
4.3 Date of Key Players Enter into Insomnia Therapy Market
4.4 Global Top Players Insomnia Therapy Headquarters and Area Served
4.5 Key Players Insomnia Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Insomnia Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Merck & Co.
5.1.1 Merck & Co. Profile
5.1.2 Merck & Co. Main Business
5.1.3 Merck & Co. Insomnia Therapy Products, Services and Solutions
5.1.4 Merck & Co. Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.1.5 Merck & Co. Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Insomnia Therapy Products, Services and Solutions
5.2.4 Sanofi Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.2.5 Sanofi Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Insomnia Therapy Products, Services and Solutions
5.3.4 Pfizer Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.3.5 Takeda Pharmaceutical Company Ltd. Recent Developments
5.4 Takeda Pharmaceutical Company Ltd.
5.4.1 Takeda Pharmaceutical Company Ltd. Profile
5.4.2 Takeda Pharmaceutical Company Ltd. Main Business
5.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Products, Services and Solutions
5.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
5.5 Purdue Pharmaceuticals L.P.
5.5.1 Purdue Pharmaceuticals L.P. Profile
5.5.2 Purdue Pharmaceuticals L.P. Main Business
5.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Products, Services and Solutions
5.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.5.5 Purdue Pharmaceuticals L.P. Recent Developments
5.6 Eisai, Co. Ltd.
5.6.1 Eisai, Co. Ltd. Profile
5.6.2 Eisai, Co. Ltd. Main Business
5.6.3 Eisai, Co. Ltd. Insomnia Therapy Products, Services and Solutions
5.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.6.5 Eisai, Co. Ltd. Recent Developments
5.7 Meda Consumer Healthcare
5.7.1 Meda Consumer Healthcare Profile
5.7.2 Meda Consumer Healthcare Main Business
5.7.3 Meda Consumer Healthcare Insomnia Therapy Products, Services and Solutions
5.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.7.5 Meda Consumer Healthcare Recent Developments
5.8 Pernix Therapeutics
5.8.1 Pernix Therapeutics Profile
5.8.2 Pernix Therapeutics Main Business
5.8.3 Pernix Therapeutics Insomnia Therapy Products, Services and Solutions
5.8.4 Pernix Therapeutics Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.8.5 Pernix Therapeutics Recent Developments
5.9 Vanda Pharmaceuticals
5.9.1 Vanda Pharmaceuticals Profile
5.9.2 Vanda Pharmaceuticals Main Business
5.9.3 Vanda Pharmaceuticals Insomnia Therapy Products, Services and Solutions
5.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.9.5 Vanda Pharmaceuticals Recent Developments
5.10 ECR Pharmaceuticals
5.10.1 ECR Pharmaceuticals Profile
5.10.2 ECR Pharmaceuticals Main Business
5.10.3 ECR Pharmaceuticals Insomnia Therapy Products, Services and Solutions
5.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.10.5 ECR Pharmaceuticals Recent Developments
5.11 Fidia Farmaceutici
5.11.1 Fidia Farmaceutici Profile
5.11.2 Fidia Farmaceutici Main Business
5.11.3 Fidia Farmaceutici Insomnia Therapy Products, Services and Solutions
5.11.4 Fidia Farmaceutici Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.11.5 Fidia Farmaceutici Recent Developments
5.12 Dainippon Sumitomo
5.12.1 Dainippon Sumitomo Profile
5.12.2 Dainippon Sumitomo Main Business
5.12.3 Dainippon Sumitomo Insomnia Therapy Products, Services and Solutions
5.12.4 Dainippon Sumitomo Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.12.5 Dainippon Sumitomo Recent Developments
5.13 Biocodex
5.13.1 Biocodex Profile
5.13.2 Biocodex Main Business
5.13.3 Biocodex Insomnia Therapy Products, Services and Solutions
5.13.4 Biocodex Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.13.5 Biocodex Recent Developments
5.14 Eli Lilly and Company
5.14.1 Eli Lilly and Company Profile
5.14.2 Eli Lilly and Company Main Business
5.14.3 Eli Lilly and Company Insomnia Therapy Products, Services and Solutions
5.14.4 Eli Lilly and Company Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.14.5 Eli Lilly and Company Recent Developments
5.15 Ebb Therapeutics
5.15.1 Ebb Therapeutics Profile
5.15.2 Ebb Therapeutics Main Business
5.15.3 Ebb Therapeutics Insomnia Therapy Products, Services and Solutions
5.15.4 Ebb Therapeutics Insomnia Therapy Revenue (US$ Million) & (2016-2021)
5.15.5 Ebb Therapeutics Recent Developments
6 North America
6.1 North America Insomnia Therapy Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapy Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Insomnia Therapy Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapy Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Insomnia Therapy Market Dynamics
11.1 Insomnia Therapy Industry Trends
11.2 Insomnia Therapy Market Drivers
11.3 Insomnia Therapy Market Challenges
11.4 Insomnia Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Au
